Cancer News

In a significant advancement for cancer treatment monitoring, researchers from The University of Texas MD Anderson Cancer Center have demonstrated that circulating tumor DNA (ctDNA) testing can...

Recent findings from a clinical trial at The University of Texas MD Anderson Cancer Center indicate that select patients with early-stage breast cancer might avoid surgery altogether. This research,...

Recent findings from a study conducted at The University of Texas MD Anderson Cancer Center present a groundbreaking possibility for early-stage breast cancer treatment: select patients may be able...

In a significant development for the field of oncology, particularly in hematologic malignancies, Nabsys has introduced its OhmX Platform as part of a collaboration with Hitachi High-Tech America...

In a significant advancement for oncology research, Nabsys has announced new installations of its OhmX Platform under the RAMP UP program in collaboration with Hitachi High-Tech America. This...

The 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, taking place from May 29 to June 2 in Chicago, is set to showcase groundbreaking cancer research from the Yale Cancer Center...

As the American Society of Clinical Oncology (ASCO) Annual Meeting approaches, Yale Cancer Center (YCC) is set to make significant contributions to the ongoing dialogue about cancer treatment and...

The landscape of cancer treatment is continually evolving, and a recent announcement from the University of Texas MD Anderson Cancer Center marks a significant milestone in this journey. Researchers,...

Recent advancements in cancer research have unveiled a promising new treatment for advanced kidney cancer, specifically targeting cases that have proven resistant to conventional therapies. A Phase I...

The recent World Indigenous Cancer Conference (WICC 2026) held in Aotearoa (New Zealand) marked a significant gathering of over 700 delegates from more than 30 countries, uniting researchers,...

Cancer treatment has evolved significantly over the years, with advancements in targeted therapies, immunotherapies, and diagnostics. However, some cancers, particularly pancreatic ductal...

The recent decision by the FDA to deny approval for the melanoma treatment RP1 has sent shockwaves through the oncology community. This treatment, which showed promise in clinical trials by shrinking...

Recent research from UT Southwestern Medical Center has unveiled a significant molecular mechanism that enables animals to adapt to environmental changes without modifying their genetic makeup. This...

The landscape of prostate cancer diagnosis is evolving, with researchers at The University of Texas MD Anderson Cancer Center identifying FOXA1 as a potentially vital protein in diagnosing aggressive...

Recent research from The University of Texas MD Anderson Cancer Center has unveiled a potentially groundbreaking diagnostic marker for aggressive forms of prostate cancer. The protein FOXA1 has...

Recent developments in cancer treatment are offering new hope for patients battling recurrent uterine cancer, a challenging condition marked by the return of cancer after initial therapy. A Phase II...

Recent advancements in cancer immunotherapy have opened new avenues for treatment, yet many patients still face obstacles with "cold" tumors—those that do not elicit an immune response. Researchers...

Recent research has illuminated the transformative potential of nanotechnology in cancer treatment, showcasing its ability to enhance precision therapy through innovative approaches. The special...

Researchers at Houston Methodist have unveiled a groundbreaking artificial intelligence platform that could transform our understanding of cellular communication in diseases such as cancer and...

Recent advancements in artificial intelligence (AI) have opened up exciting new avenues for understanding complex diseases like cancer and Alzheimer’s. Researchers at Houston Methodist have developed...